December 2015 FDA Recall Drug by Lipo Escultura Corp.
D-0860-2016 - Marketed Without An Approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Lipo Escultura Corp. on December 3, 2015 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0860-2016

Reason for Recall
Marketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, and diclofenac, a prescription non-steroidal anti-inflammatory drug, making this an unapproved drug.
Initiated
12-03-2015
Reported
06-01-2016
Quantity
unknown

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Lipo Escultura Corp.
Nationwide via Internet sales
LIPO ESCULTURA capsules, 250 mg, 60-count bottles, Distributed By: JAT Productos Naturales Corp., BROOKLYN, NY 11238, www.lipoesculturatreatment.com

Batch or Lot Expiration Information

Lot# All lots